SC 13D

Company

X4 Pharmaceuticals, Inc

Filed

February 14, 2018

Accession Number

0001193125-18-045947

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →